2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1245318088 MD FACP
Verify on CMS →

ALI BEHZADNIA, MD FACP

Endocrinology, Diabetes & Metabolism Physician in COSTA MESA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
480
Medicare Part D claims · 88 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: ALI BEHZADNIA, MD FACP is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in COSTA MESA, California with a Medicare Part D prescribing footprint of 480 claims across 88 beneficiaries — 27% brand-name prescribing .

What stands out: ALI BEHZADNIA, MD FACP filed 480 Medicare Part D claims in 2023 across COSTA MESA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

ALI BEHZADNIA, MD FACP practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

ALI BEHZADNIA, MD FACP at a glance

Quality data not reported

NPI registry status

Active

Issued 11/01/2006

NPI 1245318088

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

480 82% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALI BEHZADNIA, MD FACP is a Endocrinology, Diabetes & Metabolism Physician provider practicing in COSTA MESA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD FACP. NPI: 1245318088. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ALI BEHZADNIA, MD FACP appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD FACP credentials at 275 VICTORIA ST, COSTA MESA, CA, 92627, with a listed phone of (949) 650-0630. NPI 1245318088 was issued on 11/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BEHZADNIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 480 prescription claims written by this provider, covering 88 Medicare beneficiaries and totaling roughly $59K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

275 VICTORIA ST
COSTA MESA, CA 92627

Provider Details

NPI 1245318088
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD FACP
Gender Male
NPI Issued 11/01/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ALI BEHZADNIA, MD FACP. To verify ALI BEHZADNIA, MD FACP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ALI BEHZADNIA, MD FACP — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 480 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

480
Total Claims
$59K
Total Drug Cost
88
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,120
Total Day Supply
33,336
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$49K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
74.9 years
Avg HCC Risk Score
1.39
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
154
Metformin Hcl
30
Allopurinol
24
Glipizide Er
Glipizide
24
Hydrocortisone
24
Synthroid
Levothyroxine Sodium
20
Methimazole
19
Glipizide
12
Lantus Solostar
"Insulin Glargine
N/A
Nano 2nd Gen Pen Needle
"Pen Needle
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ALI BEHZADNIA, MD FACP fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ALI BEHZADNIA, MD FACP's 480 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BEHZADNIA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALI BEHZADNIA, MD FACP's specialty?
ALI BEHZADNIA, MD FACP specializes in Endocrinology, Diabetes & Metabolism Physician and practices in COSTA MESA, California. Credentials: MD FACP.
How much does ALI BEHZADNIA, MD FACP prescribe under Medicare Part D?
In 2023, ALI BEHZADNIA, MD FACP wrote 480 Medicare Part D claims totaling $59K in drug costs for 88 beneficiaries.
Where is ALI BEHZADNIA, MD FACP located?
ALI BEHZADNIA, MD FACP is located at 275 VICTORIA ST, COSTA MESA, CA, 92627. Phone: (949) 650-0630.
What is ALI BEHZADNIA, MD FACP's NPI number?
ALI BEHZADNIA, MD FACP's National Provider Identifier (NPI) is 1245318088, issued on 11/01/2006.
Does ALI BEHZADNIA, MD FACP prescribe more brand-name or generic drugs?
ALI BEHZADNIA, MD FACP's prescribing is 27% brand-name and 73% generic drugs by claim count, with $49K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ALI BEHZADNIA, MD FACP prescribe most often?
Based on 2023 Medicare Part D data, ALI BEHZADNIA, MD FACP's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Allopurinol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALI BEHZADNIA, MD FACP accept Medicare?
ALI BEHZADNIA, MD FACP appears in CMS Medicare data with 480 Part D claims and 88 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALI BEHZADNIA, MD FACP's credentials?
ALI BEHZADNIA, MD FACP's NPI is 1245318088 with credentials MD FACP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology